¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"functional magnetic resonance imaging"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • whispering resonance
    ±Ó¼Ó¸»°ø¸íÀ½
  • functional amblyopia
    ±â´ÉÀÌ»ó¾à½Ã
  • functional antigen
    ±â´ÉÇ׿ø
  • functional aphasia
    ±â´É¼º¾ð¾î»ó½ÇÁõ, ±â´É¼º½Ç¾îÁõ
  • functional asplenia
    ±â´É¼ºÁö¶ó¾øÀ½(Áõ)
  • functional bleeding
    ±â´ÉÀûÃâÇ÷
  • functional blindness
    ±â´É½Ã°¢»ó½Ç
  • functional capacity
    ±â´É¿ë·®
  • functional cardiovascular disease
    ±â´É¼º½É(Àå)Ç÷°üº´
  • functional congestion
    ±â´É¿ïÇ÷
  • functional deafness
    ±â´É¼º³­Ã»
  • functional death
    ±â´ÉÀû»ç¸Á
  • functional disorder
    ±â´É¼ºÀå¾Ö
  • functional dyspepsia
    ±â´É¼º¼ÒÈ­ºÒ·®
  • functional endoscopic sinus surgery
    ±â´É³»½Ã°æÄÚ°ç±¼¼ö¼ú, ±â´É³»½Ã°æºÎºñµ¿¼ö¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • functional neck dissection
    ±â´É¸ñ¼ö¼ú, ±â´É±ÙÄ¡¸ñ¼ö¼ú
  • functional group
    ÀÛ¿ë±â
  • functional hallucination
    ±â´Éȯ°¢
  • functional hand
    ±â´ÉÀǼö
  • functional hearing loss
    ±â´É³­Ã»
  • functional ileus
    ±â´ÉâÀÚ¸·ÈûÁõ, ±â´É¼ºÀåÆó¼âÁõ
  • functional impotence
    ±â´É¹ß±âºÎÀü
  • functional murmur
    ±â´É¼ºÀâÀ½, »ý¸®ÀûÀâÀ½
  • functional proteinuria
    ±â´É´Ü¹é´¢
  • functional psychosis
    ±â´ÉÁ¤½Åº´
  • functional regurgitation
    ±â´ÉÀû¿ª·ù
  • functional scoliosis
    ±â´ÉôÁÖ¿·±ÁÀ½Áõ, ±â´ÉôÁÖÃø¸¸Áõ
  • functional stricture
    ±â´ÉÇùÂø
  • functional dead space
    ±â´ÉÀûÁ×Àº°ø°£
  • functional endoscopic sinus surgery
    ±â´É³»½Ã°æÄÚ°ç±¼¼ö¼ú, ±â´É³»½Ã°æºÎºñµ¿¼ö¼ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • functional dysmenorrhea
    ±â´É¼º ¿ù°æ°ï¶õ(Áõ)(¡­êÅÌèÍÝÑññø).
  • functional dyspepsia
    ±â´É¼º ¼ÒÈ­ºÒ·®.
  • functional endoscopic sinus surgery
    ±â´É(Àû) ³»½Ã°æ ºÎºñµ¿¼ö¼ú
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ).
  • functional hallucination See hallucination
    ±â´ÉÀû ȯ°¢(ѦÒöîÜü³ÊÆ).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • functional hypogammaglobulinemia
    ±â´É¼º Àú°¨¸¶±Û·ÎºÒ¸°Ç÷Áõ
  • functional hypoglycemia
    ±â´ÉÀû ÀúÇ÷´ç.
  • functional ileus
    ±â´É¼º ÀÏ·¹¿ì½º, ±â´É¼º ÀåÆó»ö.
  • functional impotence
    ±â´É¼º À½À§(¡­ëäê×).
  • functional impotence See impotence
    ±â´É¼º ¹ß±â<¼º±³>ºÒ´É (ѦÒöàõÚúÑÃ<àõÎß>ÝÕÒö)
  • functional indigestion =f. dyspepsia
    ±â´É¼º ¼ÒÈ­ºÒ·®(Áõ).
  • functional layer
    ±â´ÉÃþ(ѦÒööµ).
  • functional layer of endometrium
    ÀڱüӸ·±â´ÉÃþ
  • functional localization
    ±â´É¼º ±¹Àç(¡­ÏÑî¤).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • amphoric resonance
    °øµ¿(¼º) °ø¸íÀ½
  • bandbox resonance
    °í⼺ °ø¸íÀ½(ÍÕóìàõÍìÙ°ëå).
  • continuous wave off-resonance
    ¿¬¼ÓÆÄ ÀÌÅ» °ø¸í
  • cough resonance
    ±âħ°ø¸íÀ½
  • level resonance
    °ø¸íÁØÀ§
  • nuclear paramagnetic resonance
    ÇÙ »óÀÚ¼º °ø¸í
  • off-resonance radiofrequence saturation pulse
    ÀÌÅ» °ø¸í °íÁÖÆÄ Æ÷È­ ÆÞ½º
  • off-resonance signal
    ÀÌÅ» °ø¸í ½ÅÈ£
  • offset-resonance pulse
    ¿ÀÇÁ¼Â °ø¸í ÆÞ½º
  • osteal resonance
    °ñ°ø¸íÀ½
  • resonance
    °ø¸í
  • resonance absorption
    °ø¸íÈí¼ö
  • resonance absorption
    °ø¸íÈí¼ö(ÍìÙ°ýåâ¥).
  • resonance chamber
    °ø¸íÇÔ(ÍìÙ°ùÞ), ¹ÝÇâÇÔ(ÚãúÂùÞ).
  • resonance condition
    °ø¸í Á¶°Ç
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • magnetic transfer contrast [=MTC]
    ÀÚÈ­Àü´Þ´ëÁ¶µµ
  • magnetic transformation
    ÀÚ±âÀüȯ
  • main magnetic field inhomogenity
    ÁÖÀÚÀåºñ±ÕÁú¼º
  • relative magnetic permeability
    »ó´ëÀûÀÚ±âÅõ°ú·Â
  • static magnetic field
    Á¤ÀÚÀå
  • volume magnetic susceptibility
    ¿ëÀûÀÚÈ­À²
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • advanced Fourier imaging
    Áøº¸Fourier¿µ»ó
  • black blood imaging
    ÈæÇ÷·ù¿µ»ó
  • bright blood imaging
    ¸íÇ÷·ù¿µ»ó
  • chemical shift imaging [=CSI]
    È­ÇÐÀûº¯À§¿µ»ó
  • color flow imaging
    »öÇ÷·ù¿µ»ó
  • diagnostic imaging
    Áø´ÜÀû¿µ»ó, ¿µ»óÁø´Ü
  • diffusion imaging
    È®»ê¿µ»ó
  • diffusion tensor imaging [=DTI]
    È®»êÅÙ¼­¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
NMRS nuclear magnetic resonance spectroscopy
PMR patient meta-record; perinatal mortality rate; periodic medical review; physical medicine and rehabi...
TMR tissue maximum ratio; topical magnetic resonance; trainable mentally retarded
TNMR tritium nuclear magnetic resonance
VEC-MR velocity encoded cine-magnetic resonance
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
(31)P-MRS 31)P magnetic resonance spectroscopy
(31)P NMR 31)P nuclear magnetic resonance
MRS 31)P-magnetic resonance spectroscopy
NMR 31)P-nuclear magnetic resonance
31P-MRS 31-Phosphorus magnetic resonance spectroscopy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • spin echo intravoxel incoherent motion imaging
    ½ºÇÉ ¿¡ÄÚÈ­ Àû¼Ò³» ºñ°áÁý ¿îµ¿ ¿µ»ó¼ú
  • static magnetic field
    Á¤ÀÚÀå
  • stop action imaging
    Á¤Áö »óÅ ¿µ»ó
  • T1 weighted FLASH imaging
    T1 °­Á¶ FLASH ¿µ»ó
  • ultrasonic imaging
    ÃÊÀ½ÆÄ ¿µ»ó
  • Zebra-stripe imaging method
    ¾ó·è¸» ¹«´Ì ¿µ»ó ¹æ¹ý
  • functional abnormality
    ±â´ÉÀû ÀÌ»ó
  • functional amblyopia
    ±â´É ¾à½Ã
  • functional aphasia
    ±â´É¼º ½Ç¾î
    È÷½ºÅ׸® ¶Ç´Â ÁßÁõ È÷½ºÅ׸®¼º Àå¾Ö¿¡ ±âÀÎÇÑ ½Ç¾îÁõ.
  • functional articulation
    ±â´É ±³ÇÕ
  • functional dead space
    ±â´ÉÀû »ç°­
  • functional disc dislocation
    °üÀý¿øÆÇÀÇ ±â´ÉÀû ÀüÀ§
  • functional disc displacement
    ±â´ÉÀû °üÀý¿øÆÇ º¯À§
  • functional dislocation with reduction
    Á¤º¹¼º ±â´ÉÀû ÀüÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
malignant melanoma: gallium imaging <radiology> Greater than50% sensitivity for primary and metastatic sites: 73% sensitivity if lesion is greater than 2 cm, 17% sensitivity if less than 2 cm, see: gallium: indications malignant melanoma
(12 Dec 1998)
gated blood pool imaging Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchroniser or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography (ventriculography, first-pass).
(12 Dec 1998)
ratio imaging fluorescence microscopy <procedure> A method of measurement of intracellular pH or intracellular calcium levels, using a fluorescent probe molecule (see fura-2), in which the two different excitation wavelengths are used and the emitted light levels compared.
If emission at one wavelength is sensitive to the intracellular ion level and emission at the other wavelength is not, then standardisation for intracellular probe concentration, efficiency of light collection, inactivation of probe and thickness of cytoplasm can all be performed automatically.
(17 Dec 1997)
ventilation/perfusion lung imaging <radiology> See: ventilation agents, perfusion agents, Biello-Siegel criteria
(12 Dec 1998)
phantoms, imaging Devices or objects in various imaging techniques used to visualise or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with X-ray or ultrasonic machines.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
hepatobiliary imaging <radiology> The hepatobiliary scan (Tc-99m DISIDA or MBF) is the initial procedure of choice to diagnose acute cholecystitis., Sensitivity 95% False negatives: acalculous cholecystitis, Specificity 95% False positives: non-fasting state, alcoholism, parenteral nutrition (TPN), acute pancreatitis, recent narcotic use, hepatocellular disease
(12 Dec 1998)
high-resolution imaging <technique> High Resolution Electron Microscopy is phase contrast microscopy of the atomic structure of materials. In most crystalline inorganic materials and a number of polymeric materials HREM allows the imaging of individual atomic columns. The images can frequently be interpreted in terms of the projected crystal potential, although it is often necessary to match the experimental images with those calculated from multislice algorithms. Allows direct measurement of lattice parameters, inspection of individual defects and grain orientation.
(05 Aug 1998)
secondary electron imaging <microscopy> Production of secondary electrons is very topography related. Due to their low energy, 5eV, only secondaries that are very near the surface (less than 10nm) can exit the sample and be examined. Any changes in topography in the sample that are larger than this sampling depth will change the yield of secondaries due to collection efficiencies. Collection of these electrons is aided by using a collector in conjunction with the secondary electron detector. The collector is a grid or mesh with a +100V potential applied to it which is placed in front of the detector, attracting the negatively charged secondary electrons to it which then pass through the grid-holes and into the detector to be counted. When a Secondary Electrons collide with the solid-state saemiconductor detector an electron-hole pairs are created which are then counted. This quantity is translated into a pixel intensity and displayed on the CRT, forming the image.
(05 Aug 1998)
neoplasm: gallium imaging <radiology> Useful: Hodgkin disease and histiocytic form of NHL poor sensitivity below the diaphragm, Burkitt lymphoma: almost 100% sensitivity, hepatoma: 90% sensitivity, melanoma: 90% sensitivity, leukaemia possibly useful: NHL: good for large and mediastinal lesions, nodal metastases from seminoma and embryonal cell carcinoma: 87% sensitivity, non-small cell lung CA: 85% sensitive not useful: head and neck, GI (especially adenocarcinoma), breast, gynaecological, kiddie tumours see: gallium: indications
(12 Dec 1998)
dark field imaging <microscopy> Using a single diffracted beam to form the image in a transmission electron microscope. This causes all regions of the specimen not of the same crystal structure and orientation as the region which produced the diffracted beam to be represented as very dark in the final image, allowing phase differentiation visually in the transmission electron microscope.
(05 Aug 1998)
diagnostic imaging Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.
(12 Dec 1998)
dipyridamole-thallium imaging <radiology> Myocardial perfusion imaging for patients who cannot exercise, dipyridamole, potent coronary vasodilator, dose: 300 mg IV, side effects relieved by aminophyllin, thallium given when: symptomatic, HR increased 10 bpm, diastolic BP decreased 10 mm Hg, 45 min after PO dose
(12 Dec 1998)
imaging Radiological production of a clinical image using X-rays, ultrasound, computed tomography, magnetic resonance, radionuclide scanning, thermography, etc.; especially, cross-sectional imaging, such as ultrasonography, CT, or MRI.
Origin: see image
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á